AstraZeneca submits preventive Covid-19 treatment for people with chronic conditions to FDA
October 5, 2021 – AstraZeneca PLC said it has asked U.S. regulators for EUA for an antibody drug that has shown strong efficacy in preventing...
[fixed][/fixed]
